In September this year, a high-level meeting on tuberculosis will take place during the UN General Assembly. In preparation for this meeting the World Health Assembly will adopt a resolution which includes the proposal for a multisectoral accountability framework. There are parallels between the accountability framework and the antibiotic resistance debate, and could contain valuable lessons for the way forward on issues such as governance, accountability and monitoring for antibiotic resistance.
ReAct is an independent network dedicated to the problem of antibiotic resistance. ReAct is a global catalyst, advocating and stimulating for global engagement on antibiotic resistance through a broad range of collaborations.
In Mumbai, The Mumbai Mission for TB Control initiative was formed to scale up TB care and tackle drug resistance. By involving private practitioners operating in the city’s urban slum areas, the initiative is showing results in terms of new case detection, early treatment and increased adherence rates.
This 71st session of the World Health Assembly offers a unique space for health specialists, in a multitude of areas affecting global health and its future, to interact, share and learn. At this year’s assembly, Mirfin Mpundu, Head of React Africa, contributed to a side brainstorming event for civil society with the title: “AMR Control: Are We Off Track?”
Wednesday, Thomas Tängdén, Medical Director, ReAct Europe, was one of the keynote speakers at one of the side events at 71st World Health Assembly in Geneva, Switzerland. The theme for the day was “Establishing antibiotic efficacy as a global public good” and the event was organized by World Federation of Public Health Associations (WFPHA).
This week is the week of the 71st World Health Assembly (WHA) in Geneva, Switzerland. Member State delegates will have a full agenda of topics to consider and reach decisions on. While antibiotic resistance is not specifically on the agenda this year, the general work programme for the WHO covers antimicrobial resistance and other relevant topics related to access to medicines will be discussed. Moreover, several side events on, or related to, antibiotic resistance will be held in conjunction with the WHA. ReAct will be speaking at three of these side-events
The situation for many children in sub-Saharan Africa is dire: a variety of infectious diseases, malnutrition and inadequate water, sanitation and hygiene infrastructure all take their toll in these most vulnerable. According to UNICEF, the estimated mortality rate in children under 5 years in sub-Saharan Africa in 2016 was 78.4 deaths per 1000 live births. We all share a responsibility to reduce these mortality rates, but how?
According to a recent publication in the Proceedings of the National Academy of Science, global antibiotic consumption in humans has increased dramatically from 2000 to 2015. The study rings a bell on the complex challenges posed by underuse, misuse and overuse of antibiotics.
As global attention and political will to address the rising tide of antibiotic resistance has increased over the last years, and a wider range of actors starting to become involved in the field, the urgency of developing global governance of antimicrobial resistance (AMR) is growing.
“Caring about antibiotic resistance is similar to reducing plastic waste or saving water”, says Dr. Windhi Kresnawati. She is a pediatrician and has worked in a remote area in Papua Island in Indonesia for the past 4 years. During this time she managed to engage various stakeholders to support and participate in a series of activities to raise their awareness on antibiotic resistance.
As we recently commemorated the World Health Day, it is interesting to remind us all of the rise and approaching fall of one of the most powerful discoveries in medical history – antibiotics. What makes them so special, and why is bacterial resistance such a major threat to human health?
Fixed dose combinations are pharmaceutical products such as tablets, ointments or suspensions where two or more antibiotics are combined in one product. In the treatment of Tuberculosis and HIV, they are vital for treatment success as they improve compliance and reduce development of resistance.
In theory, it sounds like a good idea to copy this success to other bacteria and antibiotic resistance, but in practice it is generally not so.
Costing a country’s National Action Plan on AMR appears to be a daunting and challenging task.
As Dr. Kim Faure has great experience on costing National Action Plans on AMR ReAct interviewed her to help countries with som practical steps in the process. Once the purpose of the costing exercise is understood along with the activities that are specific for antimicrobial resistance, the costing exercise can be simplified and achieved. She will highlight some practical steps that will help the process of costing.
Bacterial resistance to antibiotics gives rise to new ethical problems. Much of medical ethics prior to antibiotics has been focused on whether a certain procedure is justified, for example with respect to safety, efficacy and costs. But as antibiotic resistance has a global impact that persists over time, new questions arise that cannot be solved only by more or better science. In contrast with science, which is descriptive, ethics is normative. Ethics deals with what we ought to do or ought not to do.
It is a well-known fact that antibiotic resistant infections have a major influence on the health of people globally. Antibiotic resistance increases both mortality and morbidity due to treatment failures and lack of effective therapy. But antibiotic resistance has even more far-reaching consequences on different levels that often tend to be overlooked.
The ReAct Toolbox is a user-friendly web-based resource that provides inspiration and guidance to take action and develop national action plans on antibiotic resistance. It is built on what has been done in the past in a variety of settings, and is aligned with ongoing and current initiatives from across the globe.
ReAct is a global network of antibiotic resistance experts with nodes in Africa, Asia Pacific, Europe, Latin America and North America.
In the last 70 years the use of antibiotics has been crucial in improving countless lives and drastically reducing deaths caused by bacterial infections. The increasing development of antibiotic resistance is posing a serious threat to human health and development, the environment and for animal health. Learn more about ReAct’s work on antibiotic resistance here.
Involved in developing your country's National Action Plan? Here you find support for developing a comprehensive plan.
Doctors, pharmacists, veterinarians and other health care professionals - you have the power to take action! Learn more about how to get started.
Engagement from civil society organizations and communities is needed to tackle antibiotic resistance. Learn more about how to get involved.